Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van de Ven

Showing results (141-150 of 632) with videos related to

Pageof 64
Sort By:
Der Radiologe|July 1, 1993
[Endosonography of the esophagus and the stomach]F M Nagengast, M van de Ven, A H Naber, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|September 14, 2007
The closed city as a strategy to reduce vulnerability of urban areas for climate changeR E de Graaf, N C van de Giesen, F H M van de Ven
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1983
Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessmentJ Van Reempts, M Borgers, L Van Dael, et al.
Stroke|June 28, 2024
Angioedema After Use of Recombinant Tissue-Type Plasminogen Activators in StrokeEvelien M Hutten, Annick A J M van de Ven, Rik Mencke, et al.
Acta Orthopaedica Belgica|August 3, 2002
Genes and orthopedics: from gene to clinic and vice versaPh Debeer, L De Smet, W J M Van De Ven, et al.
Critical Reviews in Immunology|May 6, 2011
B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutationsAnnick A J M van de Ven, Ewoud B Compeer, Joris M van Montfrans, et al.
Brain Research|October 11, 1988
Purine nucleoside phosphorylase: a histochemical marker for glial cellsJ Van Reempts, B Van Deuren, M Haseldonckx, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the NetherlandsM van de Ven, V P Retèl, H Koffijberg, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 10, 2016
A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?K P M van Winssen, R C van Kleef, W P M M van de Ven
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 2, 2017
Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation studyK P M van Winssen, R C van Kleef, W P M M van de Ven
Pageof 64

Showing results (141-150 of 632) with videos related to

Sort By:
Pageof 64
Der Radiologe|July 1, 1993
[Endosonography of the esophagus and the stomach]F M Nagengast, M van de Ven, A H Naber, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|September 14, 2007
The closed city as a strategy to reduce vulnerability of urban areas for climate changeR E de Graaf, N C van de Giesen, F H M van de Ven
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1983
Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessmentJ Van Reempts, M Borgers, L Van Dael, et al.
Stroke|June 28, 2024
Angioedema After Use of Recombinant Tissue-Type Plasminogen Activators in StrokeEvelien M Hutten, Annick A J M van de Ven, Rik Mencke, et al.
Acta Orthopaedica Belgica|August 3, 2002
Genes and orthopedics: from gene to clinic and vice versaPh Debeer, L De Smet, W J M Van De Ven, et al.
Critical Reviews in Immunology|May 6, 2011
B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutationsAnnick A J M van de Ven, Ewoud B Compeer, Joris M van Montfrans, et al.
Brain Research|October 11, 1988
Purine nucleoside phosphorylase: a histochemical marker for glial cellsJ Van Reempts, B Van Deuren, M Haseldonckx, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the NetherlandsM van de Ven, V P Retèl, H Koffijberg, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 10, 2016
A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?K P M van Winssen, R C van Kleef, W P M M van de Ven
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 2, 2017
Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation studyK P M van Winssen, R C van Kleef, W P M M van de Ven
Pageof 64